Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q1 EPS of $1.09, $0.02 worse than the analyst estimate of $1.11. Revenue for the quarter came in at $486.3 million versus the consensus estimate of $492.35 million.

For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.

Earnings